Login / Signup

Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity.

Won Kim
Published in: Alimentary pharmacology & therapeutics (2021)
Keyphrases
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • type diabetes
  • high fat diet induced
  • weight gain
  • glycemic control
  • smoking cessation
  • body mass index
  • adipose tissue